Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

English (EN)·Polski (PL)·Ukraiński (UK)
Przejdź do strony domowej biblioteki Uniwersytet Ekonomiczny we Wrocławiu Link otwiera się w nowym oknie Logo biblioteki Prolib Integro - strona głównaUniwersytet Ekonomiczny we Wrocławiu

Wyszukujesz frazę ""Quality-Adjusted Life Years"" wg kryterium: Temat

  Lista filtrów
Wyrównaj
Wyświetlanie 1-20 z 16040
Tytuł:
Reference-dependent age weighting of quality-adjusted life years.
Autorzy:
Attema AE; Erasmus School of Health Policy & Management (ESHPM), Erasmus University, Rotterdam, the Netherlands.
Brouwer WBF; Erasmus School of Health Policy & Management (ESHPM), Erasmus University, Rotterdam, the Netherlands.
Pinto-Prades JL; Faculty of Economics, Universidad de Navarra, Pamplona, Spain.
Pokaż więcej
Źródło:
Health economics [Health Econ] 2022 Dec; Vol. 31 (12), pp. 2515-2536. Date of Electronic Publication: 2022 Sep 04.
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Quality of Life*
Aging*
Humans ; Aged ; Adolescent ; Young Adult ; Adult ; Aged, 80 and over ; Quality-Adjusted Life Years ; Pilot Projects ; Age Factors
Czasopismo naukowe
Szczegóły
Tytuł:
Impact of Adding Oseltamivir to Usual Care on Quality-Adjusted Life-Years During Influenza-Like Illness.
Autorzy:
Bruyndonckx R; Interuniversity Institute for Biostatistics and Statistical Bioinformatics, Data Science Institute, Hasselt University, Hasselt, Belgium; Laboratory of Medical Microbiology, Vaccine and Infectious Disease Institute, University of Antwerp, Antwerp, Belgium.
Bilcke J; Centre for Health Economic Research and Modelling Infectious Diseases, Vaccine and Infectious Disease Institute, University of Antwerp, Antwerp, Belgium. Electronic address: .
van der Velden AW; Julius Centre for Health, Sciences and Primary Care, University Medical Centre Utrecht, Utrecht, The Netherlands.
Li X; Centre for Health Economic Research and Modelling Infectious Diseases, Vaccine and Infectious Disease Institute, University of Antwerp, Antwerp, Belgium.
Hens N; Interuniversity Institute for Biostatistics and Statistical Bioinformatics, Data Science Institute, Hasselt University, Hasselt, Belgium; Centre for Health Economic Research and Modelling Infectious Diseases, Vaccine and Infectious Disease Institute, University of Antwerp, Antwerp, Belgium.
Coenen S; Laboratory of Medical Microbiology, Vaccine and Infectious Disease Institute, University of Antwerp, Antwerp, Belgium; Department of Family Medicine and Population Health, Centre for General Practice, University of Antwerp, Antwerp, Belgium.
Butler CC; Institute for Primary Care and Public Health, Cardiff University, Cardiff, England, UK.
Beutels P; Centre for Health Economic Research and Modelling Infectious Diseases, Vaccine and Infectious Disease Institute, University of Antwerp, Antwerp, Belgium.
Pokaż więcej
Źródło:
Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research [Value Health] 2022 Feb; Vol. 25 (2), pp. 178-184. Date of Electronic Publication: 2021 Oct 01.
Typ publikacji:
Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
MeSH Terms:
Quality-Adjusted Life Years*
Antiviral Agents/*therapeutic use
Influenza, Human/*drug therapy
Oseltamivir/*therapeutic use
Adolescent ; Adult ; Aged ; Antiviral Agents/economics ; Child ; Cost-Benefit Analysis ; Decision Making ; Europe/epidemiology ; Health Care Costs ; Humans ; Influenza, Human/economics ; Influenza, Human/epidemiology ; Middle Aged ; Oseltamivir/economics ; Visual Analog Scale ; Young Adult
Czasopismo naukowe
Szczegóły
Tytuł:
Cost-utility analysis of a structured medication review compared to usual care in Parkinson's disease.
Autorzy:
Oonk NGM; Department of Neurology, Medisch Spectrum Twente, Enschede, the Netherlands. .
Dorresteijn LDA; Department of Neurology, Medisch Spectrum Twente, Enschede, the Netherlands.
van den Berg AD; Department of Science and Technology, University of Twente, Enschede, the Netherlands.
van der Palen J; Department of Epidemiology, Medisch Spectrum Twente, Enschede, the Netherlands.; Section Cognition, Data and Education, University of Twente, Enschede, the Netherlands.
Movig KLL; Department of Clinical Pharmacy, Medisch Spectrum Twente, Enschede, the Netherlands.
Nijmeijer HW; Department of Neurology, Ziekenhuis Groep Twente, Almelo, the Netherlands.
van Kesteren ME; Department of Neurology, Isala Klinieken, Zwolle, the Netherlands.
Koffijberg H; Technical Medical Centre, Section Health Technology and Services Research, University of Twente, Enschede, the Netherlands.
Pokaż więcej
Źródło:
European journal of clinical pharmacology [Eur J Clin Pharmacol] 2023 Feb; Vol. 79 (2), pp. 289-297. Date of Electronic Publication: 2022 Dec 23.
Typ publikacji:
Randomized Controlled Trial; Multicenter Study; Journal Article
MeSH Terms:
Parkinson Disease*/drug therapy
Humans ; Cost-Benefit Analysis ; Medication Review ; Health Care Costs ; Pharmacists ; Quality-Adjusted Life Years ; Quality of Life
Czasopismo naukowe
Szczegóły
Tytuł:
The estimated burden of bulimia nervosa in the Middle East and North Africa region, 1990-2019.
Autorzy:
Safiri S; Research Center for Integrative Medicine in Aging, Aging Research Institute, Tabriz University of Medical Sciences, Tabriz, Iran.; Department of Community Medicine, Faculty of Medicine, Tabriz University of Medical Sciences, Tabriz, Iran.
Noori M; Student Research Committee, School of Medicine, Iran University of Medical Sciences, Tehran, Iran.
Nejadghaderi SA; Research Center for Integrative Medicine in Aging, Aging Research Institute, Tabriz University of Medical Sciences, Tabriz, Iran.; Systematic Review and Meta-analysis Expert Group (SRMEG), Universal Scientific Education and Research Network (USERN), Tehran, Iran.
Shamekh A; Student Research Committee, Tabriz University of Medical Sciences, Tabriz, Iran.
Karamzad N; Nutrition Research Center, Department of Biochemistry and Diet Therapy, School of Nutrition and Food Sciences, Tabriz University of Medical Sciences, Tabriz, Iran.
Sullman MJM; Department of Life and Health Sciences, University of Nicosia, Nicosia, Cyprus.; Department of Social Sciences, University of Nicosia, Nicosia, Cyprus.
Grieger JA; Adelaide Medical School, University of Adelaide, Adelaide, South Australia, Australia.; Robinson Research Institute, University of Adelaide, Adelaide, South Australia, Australia.
Collins GS; Centre for Statistics in Medicine, NDORMS, Botnar Research Centre, University of Oxford, Oxford, UK.
Abdollahi M; Social Determinants of Health Research Center, Shahid Beheshti University of Medical Sciences, Tehran, Iran.
Kolahi AA; Social Determinants of Health Research Center, Shahid Beheshti University of Medical Sciences, Tehran, Iran.
Pokaż więcej
Źródło:
The International journal of eating disorders [Int J Eat Disord] 2023 Feb; Vol. 56 (2), pp. 394-406. Date of Electronic Publication: 2022 Oct 27.
Typ publikacji:
Journal Article
MeSH Terms:
Bulimia Nervosa*/epidemiology
Humans ; Female ; Quality-Adjusted Life Years ; Global Burden of Disease ; Middle East/epidemiology ; Africa, Northern/epidemiology ; Prevalence ; Incidence
Czasopismo naukowe
Szczegóły
Tytuł:
Does gabapentin provide benefit for patients with knee OA? A benefit-harm and cost-effectiveness analysis.
Autorzy:
Bensen GP; Orthopaedic and Arthritis Center for Outcomes Research (OrACORe), Department of Orthopaedic Surgery, Brigham and Women's Hospital, Boston, MA, USA; Policy and Innovation eValuation in Orthopaedic Treatments (PIVOT) Center, Department of Orthopaedic Surgery, Brigham and Women's Hospital, Boston, MA, USA; Harvard Medical School, Boston, MA, USA. Electronic address: .
Rogers AC; Orthopaedic and Arthritis Center for Outcomes Research (OrACORe), Department of Orthopaedic Surgery, Brigham and Women's Hospital, Boston, MA, USA; Policy and Innovation eValuation in Orthopaedic Treatments (PIVOT) Center, Department of Orthopaedic Surgery, Brigham and Women's Hospital, Boston, MA, USA. Electronic address: .
Leifer VP; Orthopaedic and Arthritis Center for Outcomes Research (OrACORe), Department of Orthopaedic Surgery, Brigham and Women's Hospital, Boston, MA, USA; Policy and Innovation eValuation in Orthopaedic Treatments (PIVOT) Center, Department of Orthopaedic Surgery, Brigham and Women's Hospital, Boston, MA, USA. Electronic address: .
Edwards RR; Department of Anesthesiology, Brigham and Women's Hospital, Boston, MA, USA. Electronic address: .
Neogi T; Boston University School of Medicine, Boston, MA, USA. Electronic address: .
Kostic AM; Orthopaedic and Arthritis Center for Outcomes Research (OrACORe), Department of Orthopaedic Surgery, Brigham and Women's Hospital, Boston, MA, USA; Policy and Innovation eValuation in Orthopaedic Treatments (PIVOT) Center, Department of Orthopaedic Surgery, Brigham and Women's Hospital, Boston, MA, USA. Electronic address: .
Paltiel AD; Public Health Modeling Unit, Yale School of Public Health, New Haven, CT, USA. Electronic address: .
Collins JE; Orthopaedic and Arthritis Center for Outcomes Research (OrACORe), Department of Orthopaedic Surgery, Brigham and Women's Hospital, Boston, MA, USA; Policy and Innovation eValuation in Orthopaedic Treatments (PIVOT) Center, Department of Orthopaedic Surgery, Brigham and Women's Hospital, Boston, MA, USA; Harvard Medical School, Boston, MA, USA. Electronic address: .
Hunter DJ; Institute of Bone and Joint Research, Kolling Institute, University of Sydney and Rheumatology Department, Royal North Shore Hospital, Sydney, Australia. Electronic address: .
Katz JN; Orthopaedic and Arthritis Center for Outcomes Research (OrACORe), Department of Orthopaedic Surgery, Brigham and Women's Hospital, Boston, MA, USA; Policy and Innovation eValuation in Orthopaedic Treatments (PIVOT) Center, Department of Orthopaedic Surgery, Brigham and Women's Hospital, Boston, MA, USA; Harvard Medical School, Boston, MA, USA; Division of Rheumatology, Inflammation and Immunity, Brigham and Women's Hospital, Boston, MA, USA; Department of Epidemiology, Harvard T.H. Chan School of Public Health, Boston, MA, USA. Electronic address: .
Losina E; Orthopaedic and Arthritis Center for Outcomes Research (OrACORe), Department of Orthopaedic Surgery, Brigham and Women's Hospital, Boston, MA, USA; Policy and Innovation eValuation in Orthopaedic Treatments (PIVOT) Center, Department of Orthopaedic Surgery, Brigham and Women's Hospital, Boston, MA, USA; Harvard Medical School, Boston, MA, USA; Division of Rheumatology, Inflammation and Immunity, Brigham and Women's Hospital, Boston, MA, USA; Department of Epidemiology, Harvard T.H. Chan School of Public Health, Boston, MA, USA; Department of Biostatistics, Boston University School of Public Health, Boston, MA, USA. Electronic address: .
Pokaż więcej
Źródło:
Osteoarthritis and cartilage [Osteoarthritis Cartilage] 2023 Feb; Vol. 31 (2), pp. 279-290. Date of Electronic Publication: 2022 Nov 19.
Typ publikacji:
Journal Article
MeSH Terms:
Osteoarthritis, Knee*/therapy
Neuralgia*/drug therapy
Neuralgia*/etiology
Humans ; Gabapentin/therapeutic use ; Cost-Effectiveness Analysis ; Cost-Benefit Analysis ; Quality-Adjusted Life Years
Czasopismo naukowe
Szczegóły
Tytuł:
Once-weekly semaglutide versus insulin aspart for the treatment of type 2 diabetes in the UK: A long-term cost-effectiveness analysis based on SUSTAIN 11.
Autorzy:
Evans M; Diabetes Resource Centre, University Hospital Llandough, Cardiff, UK.
Chubb B; Novo Nordisk A/S, Søborg, Denmark.
Malkin SJP; Ossian Health Economics and Communications, Basel, Switzerland.
Berry S; Novo Nordisk Ltd, Gatwick, UK.
Lawson J; Novo Nordisk A/S, Søborg, Denmark.
Hunt B; Ossian Health Economics and Communications, Basel, Switzerland.
Pokaż więcej
Źródło:
Diabetes, obesity & metabolism [Diabetes Obes Metab] 2023 Feb; Vol. 25 (2), pp. 491-500. Date of Electronic Publication: 2022 Nov 02.
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Diabetes Mellitus, Type 2*/epidemiology
Diabetes Complications*/epidemiology
Humans ; Insulin Aspart/adverse effects ; Hypoglycemic Agents ; Cost-Effectiveness Analysis ; Cost-Benefit Analysis ; Quality-Adjusted Life Years ; United Kingdom/epidemiology
Czasopismo naukowe
Szczegóły
Tytuł:
Cost-effectiveness Analysis of Tisagenlecleucel Versus Blinatumomab in Children and Young Adults with Acute Lymphoblastic Leukemia: Partitioned Survival Model to Assess the Impact of an Outcome-Based Payment Arrangement.
Autorzy:
Gye A; Novartis Pharmaceuticals Australia, University of Technology Sydney, Ultimo, NSW, Australia. .
Goodall S; Centre for Health Economics Research and Evaluation (CHERE), University of Technology Sydney, Level 12, Building 10, 235 Jones Street, Ultimo, NSW, 2007, Australia.
De Abreu Lourenco R; Centre for Health Economics Research and Evaluation (CHERE), University of Technology Sydney, Level 12, Building 10, 235 Jones Street, Ultimo, NSW, 2007, Australia.
Pokaż więcej
Źródło:
PharmacoEconomics [Pharmacoeconomics] 2023 Feb; Vol. 41 (2), pp. 175-186. Date of Electronic Publication: 2022 Oct 21.
Typ publikacji:
Journal Article
MeSH Terms:
Cost-Effectiveness Analysis*
Precursor Cell Lymphoblastic Leukemia-Lymphoma*/drug therapy
Immunotherapy*/economics
Child ; Humans ; Young Adult ; Australia ; Cost-Benefit Analysis ; Quality-Adjusted Life Years ; Antibodies, Bispecific/economics ; Receptors, Antigen, T-Cell
Czasopismo naukowe
Szczegóły
Tytuł:
Cost-utility analysis of semaglutide for type 2 diabetes after its addition to the National Medical Insurance System in China.
Autorzy:
Hu S; Department of Clinical Pharmacy, Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China.
Gu S; Department of Clinical Pharmacy, Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China.
Qi C; Department of Clinical Pharmacy, Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China.
Wang S; Department of Clinical Pharmacy, Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China.
Qian F; Department of Clinical Pharmacy, Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China.
Shi C; Department of Clinical Pharmacy, Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China.
Fan G; Department of Clinical Pharmacy, Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China.
Pokaż więcej
Źródło:
Diabetes, obesity & metabolism [Diabetes Obes Metab] 2023 Feb; Vol. 25 (2), pp. 387-397. Date of Electronic Publication: 2022 Oct 23.
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Diabetes Mellitus, Type 2*/drug therapy
Insurance*
Humans ; Cost-Benefit Analysis ; Hypoglycemic Agents/therapeutic use ; Prospective Studies ; Quality-Adjusted Life Years
Czasopismo naukowe
Szczegóły
Tytuł:
The state of health in Pakistan and its provinces and territories, 1990-2019: a systematic analysis for the Global Burden of Disease Study 2019.
Corporate Authors:
GBD 2019 Pakistan Collaborators
Źródło:
The Lancet. Global health [Lancet Glob Health] 2023 Feb; Vol. 11 (2), pp. e229-e243.
Typ publikacji:
Journal Article
MeSH Terms:
Noncommunicable Diseases*/epidemiology
COVID-19*
Malnutrition*
Child ; Infant, Newborn ; Humans ; Male ; Female ; Global Burden of Disease ; Pakistan/epidemiology ; Pandemics ; Life Expectancy ; Risk Factors ; Global Health ; Quality-Adjusted Life Years ; Cause of Death
Czasopismo naukowe
Szczegóły
Tytuł:
Trends of global and regional aetiologies, risk factors and mortality of lower respiratory infections from 1990 to 2019: An analysis for the Global Burden of Disease Study 2019.
Autorzy:
Kang L; Department of Epidemiology and Biostatistics, School of Public Health, Peking University, Beijing, China.
Jing W; Department of Epidemiology and Biostatistics, School of Public Health, Peking University, Beijing, China.
Liu J; Department of Epidemiology and Biostatistics, School of Public Health, Peking University, Beijing, China.
Liu M; Department of Epidemiology and Biostatistics, School of Public Health, Peking University, Beijing, China.
Pokaż więcej
Źródło:
Respirology (Carlton, Vic.) [Respirology] 2023 Feb; Vol. 28 (2), pp. 166-175. Date of Electronic Publication: 2022 Oct 09.
Typ publikacji:
Journal Article
MeSH Terms:
Respiratory Tract Infections*/epidemiology
Respiratory Tract Infections*/etiology
Air Pollution*
Child ; Adult ; Humans ; Child, Preschool ; Global Burden of Disease ; Risk Factors ; Streptococcus pneumoniae ; Global Health ; Quality-Adjusted Life Years
Czasopismo naukowe
Szczegóły
Tytuł:
Cost-Utility Analysis of Esketamine for Patients with Treatment-Resistant Depression in Italy.
Autorzy:
Rognoni C; Centre for Research on Health and Social Care Management (CERGAS), SDA Bocconi School of Management, Bocconi University, Via Sarfatti 10, 20136, Milan, Italy. .
Falivena C; Centre for Research on Health and Social Care Management (CERGAS), SDA Bocconi School of Management, Bocconi University, Via Sarfatti 10, 20136, Milan, Italy.
Costa F; Centre for Research on Health and Social Care Management (CERGAS), SDA Bocconi School of Management, Bocconi University, Via Sarfatti 10, 20136, Milan, Italy.
Armeni P; Centre for Research on Health and Social Care Management (CERGAS), SDA Bocconi School of Management, Bocconi University, Via Sarfatti 10, 20136, Milan, Italy.
Pokaż więcej
Źródło:
PharmacoEconomics [Pharmacoeconomics] 2023 Feb; Vol. 41 (2), pp. 209-225. Date of Electronic Publication: 2023 Jan 20.
Typ publikacji:
Journal Article
MeSH Terms:
Depressive Disorder, Major*
Serotonin and Noradrenaline Reuptake Inhibitors*
Humans ; Cost-Benefit Analysis ; Depression ; Nasal Sprays ; Reproducibility of Results ; Antidepressive Agents/therapeutic use ; Quality-Adjusted Life Years
Czasopismo naukowe
Szczegóły
Tytuł:
Spatial and temporal patterns of colorectal cancer in Asia, 1990-2019.
Autorzy:
Sharma R; Humanities and Social Sciences, National Institute of Technology Kurukshetra, Kurukshetra, India. .
Rakshit B; Economics and Business Environment, Indian Institute of Management Jammu, Jammu and Kashmir, India.
Pokaż więcej
Źródło:
International journal of clinical oncology [Int J Clin Oncol] 2023 Feb; Vol. 28 (2), pp. 255-267. Date of Electronic Publication: 2022 Dec 15.
Typ publikacji:
Journal Article
MeSH Terms:
Colorectal Neoplasms*/epidemiology
Humans ; Quality-Adjusted Life Years ; Risk Factors ; Asia/epidemiology ; Incidence ; Global Health
Czasopismo naukowe
Szczegóły
Tytuł:
Cost-effectiveness of office-based buprenorphine treatment for opioid use disorder.
Autorzy:
Qian G; Department of Management Science and Engineering, Stanford University, Stanford, CA, USA. Electronic address: .
Rao I; Department of Management Science and Engineering, Stanford University, Stanford, CA, USA.
Humphreys K; Center for Innovation to Implementation, US Department of Veterans Affairs, VA Palo Alto Health Care System, Palo Alto, CA, USA; Department of Psychiatry and Behavioral Sciences, Stanford University, Stanford, CA, USA.
Owens DK; Department of Health Policy, School of Medicine, and Stanford Health Policy, Freeman-Spogli Institute for International Studies, Stanford University, Stanford, CA, USA.
Brandeau ML; Department of Management Science and Engineering, Stanford University, Stanford, CA, USA.
Pokaż więcej
Źródło:
Drug and alcohol dependence [Drug Alcohol Depend] 2023 Feb 01; Vol. 243, pp. 109762. Date of Electronic Publication: 2022 Dec 30.
Typ publikacji:
Journal Article
MeSH Terms:
Buprenorphine*/therapeutic use
Opioid-Related Disorders*/drug therapy
Humans ; Cost-Benefit Analysis ; Quality-Adjusted Life Years
Czasopismo naukowe
Szczegóły
Tytuł:
Current status and temporal trend of disease burden of thyroid cancer in China from 1990 to 2019.
Autorzy:
Zhang MN; Department of Epidemiology and Biostatistics, School of Public Health, Tianjin Medical University, Tianjin, China.; Tianjin Key Laboratory of Environment, Nutrition and Public Health, Tianjin, China.; Center for International Collaborative Research on Environment, Nutrition and Public Health, Tianjin, China.
Liang XY; Tianjin Medical University General Hospital, Tianjin, China.
Li MT; Department of Epidemiology and Biostatistics, School of Public Health, Tianjin Medical University, Tianjin, China.; Tianjin Key Laboratory of Environment, Nutrition and Public Health, Tianjin, China.; Center for International Collaborative Research on Environment, Nutrition and Public Health, Tianjin, China.
Zhi XY; Department of Epidemiology and Biostatistics, School of Public Health, Tianjin Medical University, Tianjin, China.; Tianjin Key Laboratory of Environment, Nutrition and Public Health, Tianjin, China.; Center for International Collaborative Research on Environment, Nutrition and Public Health, Tianjin, China.
Yan QY; Department of Epidemiology and Biostatistics, School of Public Health, Tianjin Medical University, Tianjin, China.; Tianjin Key Laboratory of Environment, Nutrition and Public Health, Tianjin, China.; Center for International Collaborative Research on Environment, Nutrition and Public Health, Tianjin, China.
Zhu H; Department of Epidemiology and Biostatistics, School of Public Health, Tianjin Medical University, Tianjin, China.; Tianjin Key Laboratory of Environment, Nutrition and Public Health, Tianjin, China.; Center for International Collaborative Research on Environment, Nutrition and Public Health, Tianjin, China.
Xie J; Department of Epidemiology and Biostatistics, School of Public Health, Tianjin Medical University, Tianjin, China.; Tianjin Key Laboratory of Environment, Nutrition and Public Health, Tianjin, China.; Center for International Collaborative Research on Environment, Nutrition and Public Health, Tianjin, China.
Pokaż więcej
Źródło:
Asia-Pacific journal of clinical oncology [Asia Pac J Clin Oncol] 2023 Feb; Vol. 19 (1), pp. 196-205. Date of Electronic Publication: 2022 Jun 12.
Typ publikacji:
Journal Article
MeSH Terms:
Cost of Illness*
Thyroid Neoplasms*/epidemiology
Female ; Humans ; Male ; Quality-Adjusted Life Years ; Incidence ; China/epidemiology
Czasopismo naukowe
Szczegóły
Tytuł:
Global burden of prostate cancer attributable to smoking among males in 204 countries and territories, 1990-2019.
Autorzy:
Zhang H; School of Medicine, University of Electronic Science and Technology of China, Chengdu, China.; Department of Nephrology, Sichuan Provincial People's Hospital, University of Electronic Science and Technology of China, Chengdu, China.
Huang D; Department of Urology, Zhongshan Hospital, Xiamen University, Xiamen, China.
Zhang Y; School of Medicine, University of Electronic Science and Technology of China, Chengdu, China.
Wang X; The George Institute for Global Health, University of New South Wales, Level 5, 1 King Street, Newtown, NSW, 2042, Australia. .
Wu J; Department of Urology, Xuanwu Hospital, Capital Medical University, Beijing, 100053, China. jiangt_.
Hong D; School of Medicine, University of Electronic Science and Technology of China, Chengdu, China. .; Department of Nephrology, Sichuan Provincial People's Hospital, University of Electronic Science and Technology of China, Chengdu, China. .; Renal Department and Nephrology Institute, School of Medicine, Sichuan Provincial People's Hospital, University of Electronic Science and Technology of China, Chengdu, 610072, China. .
Pokaż więcej
Źródło:
BMC cancer [BMC Cancer] 2023 Jan 26; Vol. 23 (1), pp. 92. Date of Electronic Publication: 2023 Jan 26.
Typ publikacji:
Journal Article
MeSH Terms:
Smoking*/adverse effects
Smoking*/epidemiology
Prostatic Neoplasms*/epidemiology
Male ; Humans ; Aged ; Quality-Adjusted Life Years ; Tobacco Smoking/adverse effects ; Tobacco Smoking/epidemiology ; Disability-Adjusted Life Years ; Global Health
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Prioritization of intervention domains to prevent cardiovascular disease: a country-level case study using global burden of disease and local data.
Autorzy:
Wilson N; Department of Public Health, University of Otago, Wellington, New Zealand. .
Cleghorn C; Department of Public Health, University of Otago, Wellington, New Zealand.
Nghiem N; Department of Public Health, University of Otago, Wellington, New Zealand.
Blakely T; School of Population and Global Health, The University of Melbourne, Parkville, VIC, Australia.
Pokaż więcej
Źródło:
Population health metrics [Popul Health Metr] 2023 Jan 26; Vol. 21 (1), pp. 1. Date of Electronic Publication: 2023 Jan 26.
Typ publikacji:
Journal Article
MeSH Terms:
Cardiovascular Diseases*/prevention & control
Humans ; Global Burden of Disease ; Diet ; Risk Factors ; Fruit ; Quality-Adjusted Life Years
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Cost-effectiveness of an insertable cardiac monitor in a high-risk population in the US.
Autorzy:
Elkind MSV; Department of Neurology, Vagelos College of Physicians and Surgeons, and Department of Epidemiology, Mailman School of Public Health, Columbia University, New York, NY, USA.
Witte KK; Leeds Institute for Cardiovascular and Metabolic Medicine, University of Leeds, Leeds, UK.; University Clinic, RWTH, Aachen, Germany.
Kasner SE; Department of Neurology, University of Pennsylvania, Philadelphia, PA, USA.
Sawyer LM; Symmetron Limited, 8 Devonshire Square, London, EC2M 4PL, UK. .
Grimsey Jones FW; Symmetron Limited, 8 Devonshire Square, London, EC2M 4PL, UK.
Rinciog C; Symmetron Limited, 8 Devonshire Square, London, EC2M 4PL, UK.
Tsintzos S; Medtronic, Mounds View, MN, USA.
Rosemas SC; Medtronic, Mounds View, MN, USA.
Lanctin D; Medtronic, Mounds View, MN, USA.
Ziegler PD; Medtronic, Mounds View, MN, USA.
Reynolds MR; Baim Institute for Clinical Research, Boston, MA, USA.; Lahey Hospital and Medical Center, Burlington, MA, USA.
Pokaż więcej
Źródło:
BMC cardiovascular disorders [BMC Cardiovasc Disord] 2023 Jan 25; Vol. 23 (1), pp. 45. Date of Electronic Publication: 2023 Jan 25.
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Atrial Fibrillation*/diagnosis
Atrial Fibrillation*/drug therapy
Humans ; Administration, Oral ; Anticoagulants/administration & dosage ; Cost-Benefit Analysis ; Hemorrhage ; Quality-Adjusted Life Years ; Stroke ; Clinical Trials as Topic
Czasopismo naukowe
Szczegóły
Tytuł:
Mortality and disability-adjusted life years for smoking-attributed cancers from 1990 to 2019 in the north Africa and middle east countries: a systematic analysis for the global burden of disease study 2019.
Autorzy:
Rezakhani L; Fertility and Infertility Research Center, Health Technology Institute, Kermanshah University of Medical Sciences, Kermanshah, Iran.; Department of Tissue Engineering, School of Medicine, Kermanshah University of Medical Sciences, Kermanshah, Iran.
Darbandi M; Research Center for Environmental Determinants of Health (RCEDH), Health Institute, Kermanshah University of Medical Sciences, Kermanshah, Iran.
Khorrami Z; Ophthalmic Epidemiology Research Center, Research Institute for Ophthalmology and Vision Science, Shahid Beheshti University of Medical Sciences, Tehran, Iran.
Rahmati S; Cancer Research Center, Shahrekord University of Medical Sciences, Shahrekord, Iran.
Shadmani FK; Research Center for Environmental Determinants of Health (RCEDH), Health Institute, Kermanshah University of Medical Sciences, Kermanshah, Iran. .
Pokaż więcej
Źródło:
BMC cancer [BMC Cancer] 2023 Jan 24; Vol. 23 (1), pp. 80. Date of Electronic Publication: 2023 Jan 24.
Typ publikacji:
Journal Article
MeSH Terms:
Global Burden of Disease*
Neoplasms*/epidemiology
Male ; Female ; Humans ; Disability-Adjusted Life Years ; Risk Factors ; Smoking/adverse effects ; Smoking/epidemiology ; Lebanon ; Quality-Adjusted Life Years ; Global Health
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Direct impact of COVID-19 by estimating disability-adjusted life years at national level in France in 2020.
Autorzy:
Haneef R; Department of Non-Communicable Diseases and Injuries, Santé Publique France, Saint-Maurice, France.
Fayad M; Department of Data science, Santé Publique France, Saint-Maurice, France.
Fouillet A; Department of Data science, Santé Publique France, Saint-Maurice, France.
Sommen C; Department of Data science, Santé Publique France, Saint-Maurice, France.
Bonaldi C; Department of Data science, Santé Publique France, Saint-Maurice, France.
Wyper GMA; School of Health & Wellbeing, University of Glasgow, Glasgow, United Kingdom.
Pires SM; National Food Institute, Technical University of Denmark, Lyngby, Denmark.
Devleesschauwer B; Department of Epidemiology and Public Health, Sciensano, Brussels, Belgium.; Department of Translational Physiology, Infectiology and Public Health, Ghent University, Merelbeke, Belgium.
Rachas A; Department of Strategy, Studies and Statistics, French National Health Insurance: Caisse nationale de l'assurance maladie (Cnam), Paris, France.
Constantinou P; Department of Strategy, Studies and Statistics, French National Health Insurance: Caisse nationale de l'assurance maladie (Cnam), Paris, France.
Levy-Bruhl D; Department of Infectious Diseases, Santé Publique France, Saint-Maurice, France.
Beltzer N; Department of Non-Communicable Diseases and Injuries, Santé Publique France, Saint-Maurice, France.
Gallay A; Department of Non-Communicable Diseases and Injuries, Santé Publique France, Saint-Maurice, France.
Pokaż więcej
Źródło:
PloS one [PLoS One] 2023 Jan 24; Vol. 18 (1), pp. e0280990. Date of Electronic Publication: 2023 Jan 24 (Print Publication: 2023).
Typ publikacji:
Journal Article
MeSH Terms:
COVID-19*/epidemiology
Disabled Persons*
Male ; Humans ; Female ; Disability-Adjusted Life Years ; Quality-Adjusted Life Years ; Post-Acute COVID-19 Syndrome ; SARS-CoV-2 ; France/epidemiology
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Wyświetlanie 1-20 z 16040

Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies

Prześlij opinię

Twoje opinie są dla nas bardzo ważne i mogą być niezwykle pomocne w pokazaniu nam, gdzie możemy dokonać ulepszeń. Bylibyśmy bardzo wdzięczni za poświęcenie kilku chwil na wypełnienie krótkiego formularza.

Formularz